SlideShare a Scribd company logo
DRUG BOOK
SIGNATURE OF SUBJECT COORDINATOR SIGNATURE OF EXTERNAL
SIGNATURE OF INTERNAL
INDEX
SR.NO
NAME OR
CLASSIFICATIONS
NAME OF THE DUG
1
ANALGESICS AND
ANESTHETICS
 ACETAMINOHEN
 ASPIRIN
 FENTANYL
 IBUPROFEN
 KETAMINE
 MIDAZOLAM
 PROPOFOL
2
ANTICONVULSANTS  PHENYTOIN
 PHENO BARBITOL
 SODIUM VALPROATE
 CARBOMAZEPINE
3
ANTI COAGULANTS  HEPARIN
 WARFARIN
4
ANTIHYPERTENSIVE  ATENDOL
 PROPRANOLAL
 NEFEDIPINE
 VERAPAMIL
5
DIURETICS  ACETAZOLAMIDE
 FRUZEMIDE
 MANNITOL
 SPIRANOLACTONE
6
VASODILATORS  SODIUM NITROPRUSSIDE
 HYDRALAZINE
7
ANTI TUBERCULOSIS DRUGS  ISONIAZID
 PYRAZINAMIDE
 RIFAMPICIN
 ERYTHROMYCIN
8 ANTI LEPROSY DRUGS  DAPSON
9
BROCHO DILATORS  SALBUTAMOL
 ATROPINE SULPHATE
 TERBUTALINE
10
ANTI MALARIAL DRUGS  CHLOROQUININE PHOSPHATE
 PRIMAQUININE PHOSPHATE
11
ANTIVIRALS
 ACYLOVIR
 RIBOVIRIN
 ZIDOVUDINE
12
CARDIOTONICS
 DGOXIN
13
ANTI BIOTICS  AMPICILLIN
 PENCILLIN
 TETRACYCLIN HYDROCHLORIDE
 CEFOTAXIM
14
ANTI RETROVIRALS  INOINAVIR SULPHATE
 ZINDOVUDINE
15
ANTI NEOPLASTIC DRUGS  CYCLO PHOSPHAMIDE
 VINCRISTINE SULPHATE
ANALAGESICS
&
ANESTHETICS
SL
NO.
NAME
OF
DRUG
TRADE
NAME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAINDI
RATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
1 ACET
AMIN
OPHE
N
AASE
AEGI
NA
ORA
L
300M
g
 It exhibits
analysis
action by
peripheral
blockage of
pain
impulse
generation
 It produces
antipyretics
effect by
inhibiting
the
hypothalam
ic heart
regulation
center.
 Mild,
moderate
pain
 Post
impyrexi
a
 Rheumat
ic fever
 Hypersensiti
vity
 Nausea
 Vomiting
 Allergic
reaction
 Skin
rashes
 Diarrhea
 Ulceration
 Perforatio
n
 Hemaehag
e
 Neurosis
 Aplastic
anemia
 Check
for any
C.I
 Check
for any
adverse
reaction.
 Follow
the
principle
s of drug
administr
ation.
2
aspirin Arced Oral 3-25
mg
80-
100-
mg/kg
 It inhibits
analgesic
action by
antipyretic
action
 A non-
steroidal
salicylate
that inhibits
prosta
glandins
synthesis
acts on the
hypothalam
us heart
regulating
center.
 A substance
that
stimulate
platelet
aggregates.
 It reduces
inflammatio
n, pain,
decreases
fever.
Analgesia
Fever
MI
Stroke
Ischemic
attack
Kawasaki
disease
Hypersensitivi
ty
Bleeding
disorders
Chicken ox
GI bleeding o
ulceration
Hepatic
impairment
Allergy
Pregnancy
lactation
 GI distress
 Allergic
reaction
 Bronchospa
sm
 Pursuits
 Urticaria
 Headache
 Tinnitus
 Difficulty in
hearing
 Lethargy
 Confusion
 Drowsiness’
Use liquid
form for
children &
patient who
are
difficulty in
swallowing
In children
don’t
exceeds
five dos in
24hrs
Check vital
signs
Chick for
any rashes
SL
NO.
NAME
OF
DRUG
TRAD
E
NAME
ROUTE DOSE MODE OF
ACTION
INDICA
TION
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
3 IBUPR
OFEN
- 8-12mg
600-8—
mg
0.4-
0.6gm
Iv
Oral
 It Is a synthetic
compound
having
analgesic &
mid anti-
inflammatory
effect
 Fever
 pain
a cute peptic
ulcer
gastric
irritation
dyspnea
GI bleeding
jaundice
 check for
side
effects
SL
NO.
NAME
OF
DRUG
TRAD
E
NAME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATIO
N
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
4 FENT
ANYL
fend
cap
O IV 0.5-
3mg/kg
0.5-
1mg/kg
 it inhibits
prostaglandi
n synthesis
 pain
 anesthesia
hypersensit
ivity
dyspnea
peptic ulcer
rhinitis
nausea
vomiting
 check for
any side
effect &
adverse
reaction
 assess vital
signs
regularly
SL
NO.
NAME
OF
DRUG
TRAD
E
NAME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATIO
N
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
5 PROP
OFOL
- IV 1-
2mgl/kg
It Is an liquid
used as 1%
emulsion. It is
used for i.v
indication &
short duration
anesthesia.
 Sedation
 ECT
hypersensit
ivity
nausea
vomiting
pain
headache
involuntary
muscle
contraction
 check for
any side
effect
 monitor
vital signs
ANTI CONVULSANT
SL
NO.
NAME
OF
DRUG
TRAD
E
NAME
ROU
TE
DOSE MODE OF
ACTION
INDICAT
ION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
1 PHEN
YTOIN
EPTOI
N
Oral 5
mg/kg
May stabilize
neuronal and
limit seizure
activity either
by increasing
influx of ion
across the cell
membrane is to
monitor cortex
of nerve
impulse
Tonic
clone
seizure
 Static
epilepti
cs
Hypersensiti
vity
Hepatic
dysfunctio
n
Hypotension
Respiratory
depression
Ataxia
Diplopia
Vomiting
Constipation
Toxichepatit
es
 don’tgive
IM unless
dosage
adjustment
 Divided
dosegive
with or
after meal.
 Don’t stop
drug
suddenly
 Monitor
drug level.
SL
NO.
NAME
OF
DRUG
TRAD
E
NAME
ROUTE DOSE MODE OF
ACTION
INDICAT
ION
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
2 Sodium
valproa
te
- Oral/IV 10-15
mg/kg
Unknown
facilitated the
effects to
inhibit neuron
transmitter
GABA
 Sample
complex
seizure
 Mixed
seizure
type
Hypersen
situity
Hepatic
disease
Children
younger
than
10years
Urea cycle
disorders
Dizziness
Headache
Insomnia
Chest pain
Hypertensio
n
Blurred
vision
Abdominal
pain
Anorexia
Diarrhea
Alopecia
 Obtain
lives
function
test
 Monitor
drug level
 Tell patient
to take
drug c
food/milk
to reduce
and verse
GJ effect.
SL
NO.
NAME
OF
DRUG
TRA
DE
NAM
E
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
3
Diaz
epam
- IV/IM
oral
0.12-
0.8
mg/kg/
day
0.04-
0.3
mg/kg
 A
benzodiazepin
e that
depresses all
levels of the
CNS by
enhancing the
action of
gamma amino
butyric acid, a
major
inhibitory
neurotransmitt
er in the brain
 It produces
anxiolytic
effect, elevates
the seizure
threshold
Cough
Anxiety
Skeletal
muscle
relaxation
Preanesthe
sia
Alcohol
arthdeval
Status
epileptics
Hypersensitiv
ity
Angle closure
glaucoma
Coma
CNS
depression
Respiratory
depression
Sever
uncontrolled
pain
Pain IM
injection
Somnolenc
e
Fatigue
Ataxia
Slurred
speech
Headache
Constipatio
n
Nausea
Blurred
vision
 When the
patient
have
sudden
change of
position
can cause
of zziness
 In street the
patient to
avoid
alcohol
while
taking
diazepam
 Monitor
vital signs.
ANTIBIOTICS
SL
NO
.
NAME
OF
DRUG
TR
AD
E
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
1 AMPICI
LLIN
- ORAL
/IV
25-
30mg/k
g
 Inhibit cell-
wall synthesis
during bacterial
multiplication.
UTI
G1
infection
Skin
infection
Hypersensitiv
ity
Seizure
Lethargy
Vomiting
Diarrhea
Nausea
Anaxity
Confusion
Before
giving
drug ask
Pt about
degree of
reaction to
penicillin
Monitor
Na+ level
SL
NO
.
NAME
OF
DRUG
TR
AD
E
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 Penicil
lin
- IV/1m
l oral
500mg  It is bind to
the bacterial
cell wall
synthesis.
 The protects
the penicillin
from
enzymatic
degradation.
Respirator
y
infection
UTI
Meningoc
occal
infection
hypersensiti
vity
seizure
diarrhea
nausea
vomiting
headache
oral or
vaginal
candidiasis
anemia
monitor the
patients
pulse & B.P
notify the
vomiting or
diarrhea
monitor
respiratory
rate& any
rashes
Cheek for
any side
effect.
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
3 AMIKA
CIN
Amik
in
IV/IM 250 mg
for
12hrs
 It is an
aminoglycoside
antibiotic that
irreversibly
binds to protein
or bacterial
ribosomes.
 Interferes
protein
synthesis of
susceptible
microorganism
Typhoid
Bronchitis
UTI
Hypersensitiv
ity
Pain in
duration
Thromboph
lebitis
Difficulty
in
breathing
Drowsiness
Weakness
 Monitor
patient for
swelling
 Monitor
respiratory
rate.
 Monitor
urine
output
 Monitor the
patient
pulse &
B.P

SL
NO
.
NAME
OF
DRUG
TR
AD
E
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
4 TETRAC
YCLIC
HYDRO
CHLOID
E
- Oral 25-
30mg/k
g
 May exert
bacteriostatic
effect by
binding to
protein or
bacterial
ribosomes.
 They inhibit
protein
synthesis.
Grana
positive
infections
Rectal
infection n
Urethral &
endo-
cervical
infection
Soretheoat
Glossites
Diarrhea
Hypersensitiv
ity
Nausea
Vomiting
Skin rashes
Obtain
specimen
for culture
&
sensitivity.
Check
patient
tongue for
infection
Check for
any side
effect
ANTI COAGULANTS
SL
NO
.
NAME
OF
DRUG
TR
AD
E
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
1 HEARIN - IV 25-
50units
/kg hr
 Accelerator
reaction of
anti-thrombin
complex and
deactivates
thrombin
preventing of
fibrinogen to
fibrin.
Pulmonary
embolism
Deseirited
intravascu
lar
coagulati
on.
Hypersensitiv
ity
Active
bleeding
Ascorbic acid
deficiency
Fever
Rhinitis
Irritation
Peuritis
Cut Icaria
Dew blood
to
establishes
baseline
coagulatio
n before
therapy .
Check
vital
SL
NO
.
NAME
OF
DRUG
TR
AD
E
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAIND
IRATION
SIDE
EFFECT
NURSING
RESPONSI
BILITIES
2 WARFA
RIN
   
ANTI-HYPERTENSIVE
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 Epineph
rine
- 1m, sc
IV
0.2-
0.5 ml
0.25m
g
 It has stimulant
action on
predominant B
receptor
 It dilates the
blood vessels of
the skeletal
muscle on
account of
predocinderent
of B2 receptor.
 It increases
heart rate &
myocardial
contractility.
Anaphylac
tic shock
Bronchial
asthma
Cardiac
resusutati
on
Open
angle
gleeman
Angoneur
otic
edema of
larynx
Vertigo
hypotensio
n
Hypotension
Palpation
Angina
Nausea
Headache
Vomiting
Sweating
 Use
extrence
caution in
alkylate &
preparing
doses
 Any solution
of adrenaline
that is teen to
panic should
not be given.
 Bp should be
cheeked
energy
15minuts.
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 Propran
olol
- Oral 0.5-
1mg/k
g/day
 An anti-
hypertensive,
antianginal,
antiarrhythmic, &
ant migraine
agent that blocks
beta1,beta2,
adrenergic
receptors.
 It decreases
oxygen
requirements.
 It slows Av
conduction.
 Therapeutic
effect: decreases
cardiac out put
Angina
Arrhythmi
c
Hypertrop
hy sub
aortic
stenosis.
Migraine
headache
MI
Essential
tremors
Asthenia
Beady
card
Cardiogen
ic shock
Raynaud
& syndrome
CHF
Pregnancy
Lactation
 Diminished
sexual
ability
 Drowsiness
 Difficulty
sleeping
 Unusual
fatigue
 Beady
cardiac
 Depression
 Diarrhea
 Anxiety
 Pruritus
 Always
cheek patents
apical pulse
before giving
drug.
 Pulse rate
occurs a rolel
drug & notify
pees cubes
incredibly
 Give drug
consistently
meals foods.
May increase
absorption of
propranolol
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
3 AMLO
DIPINE
- oral 5-
10mg
It has antianginal
antihypertensive
actor
A calcium
channel blockers
that inhibits ca
moucment across
cardiac
&vascular
smooth cell
membrane.
Therapeutic
effect decreases
peripheral
vascular
resistance & BP
by vasodilation.
Hypertensi
on
Angina
Renal
inepairien
t
Hyper
sensitivity
Severe
hypotension
Aortic
stenosis
Heart
failure
Severe
hepatic
diseases
 Peripheral
edema
 Headache
 Flushing
 Dizziness
 Palpitation
 Nausea
 Fatigue
 Chest pain
 Beady cardia
 Orthostatic
hypotension
 Tel the
patient to take
nitroglycerine
for acute
angina
symptoms.
 Notify cline
of irregular
heartbeat,
shortness of
breath,
shortness of
breath ,
swelling of
feet, hand etc.
 Monitor BP
continuously.
SL
NO
.
NAME
OF
DRUG
TRAD
E
NAME
ROU
TE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
4 HYDR
ALAZI
NE
- Oral/
IV
0.75-
1mg/k
g/day
 An anti-
hypertensive
direct
vasodilating
effects on
arterials.
 Therapeutic
effect: decreases
BP &
resistance.
Hypertensi
on
Failure of
heart
Hypersens
itivity
Coronary
artery
disease
CNA
Renal
caiemant
 Headache
 Palpitation
 Tachycardi
a
 GI
disturbances
 Nausea
 Vomiting
 Peripheral
ederea
 Dizziness
 Nasal
congestion
 Flushed
face
CBC, left
cell
purparation
& ANA litxe
diter
mination
should be
performed
before
surgery
Advise
precaution
from
orthostatic
hypotension.
For IV use
monitor BP
every
5minutes
DIURETICS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 FUOSE
MIDE
- Oral/
IV/
IM
1-
6mg/kg
day in
6-12 hr
1-2
mg/kg
(IV,IM)
 Aldop duretic
that enhances
excretion of
sodium chloride
& potassium by
direct action at
the ascending
liner of the loop
of Henley
 It produces
decrees & lower
BP
Edema
Hypertensi
on
Anuria
Hepatic
coma
Sever
electrolyte
depletion
Pregnancy
lactation
 increased
urinary
frequency
 nausea
 dyspepsia
 abdominal
camps
 diarrhea
 constipation
 electrolyte
disturbance
 dizziness
 to prevent
nocturia give
PO&IM
preparation on
the morning
 monitor
fluid intake &
output
electrolytes,
BUN & co2
level
frequency
 watch for s/s
of
hypokalemia
 monitor
glucose level
in DM patient
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 SPIRON
OLACT
ONE
-
PO 1.5-3.3
mg/kg/d
ay in 1-
2
divided
doses
 an potassium
sparing durative
that intefeve
sodium
reabsorption by
competitively
inhibiting the
action of
aldosterone in
the distal tubule,
this promoting
Na & H2o
excretive &
 it produce
diuresis lower
BP
edema
hypertensi
on
hirsutine
mypolcale
nier
primacy
aldostero
ne
acute renal
insufficienc
y
anuria
BUN &
serum
creatin level
increase
Hyperkale
mia
Pregnancy
Lactation
 Hypertension
 dehydration
 nausea
 lethargy
 dyspepsia
 abdominal
camps
 diarrhea
 constipation
 confusion
Assess the
patent
actually
Monitor vital
signs
Cheek for
any rashes
Cheek for
abdominal
discomfort
Give the
drug meals
to enhance
the
absorption
Instruct the
patient to
report mental
confusion
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
3 TRIAM
TEREN
E
- Oral 2-4
mg/kg/d
ay in
single
dose
 A potassium
sparing
directive that
inhibits sodium,
potassium
ATPase
 It increases
odium &
decreases
potassium
excretion
 It produces
decreases &
lowers BP
Edema
Hypertensi
on
Hyperkale
mia
Renal
disease
Hepatic
disease
Pregnancy
lactation
 fatigue
 nausea
 diarrhea
 abdominal
pain
 leg cramps
 headache
 anorexia
 rash
 dizziness
 ECG
changes
Assess the
patient
actually
Monitor vital
signs
Cheek for
any rashes
Monitor
ECG
Monitor
BUN &
creatin
level
Cheek for
fluid
electrolyte
imbalance
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
4 XIPAMI
DE
- Oral 10-
20mg
 It is peniacysite
of action is the
cortical segment
of early distal
tubes.
 If inhibit
sodium
reabsorption,
choice & water
are retained in
the tubule
secondly
 Relaxant effect
on arterioles &
elevation of
blood.
Edema
Hepatic
crepauien
t
Renal
crepavierien
t
Acute
electrolyte
unbalance
Cirrhosis
of lives
 Weakness
 Fatigue
 Muscle camp
 GI
disturbance
 Hearing loss
Monitor vital
signs
Monitor
patient for
allergic
reaction
Monitor to
chart
Provide right
dosage at
right time.
VASODILATOR
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 SODIUM
NITROP
RUSSID
E
- IV/
oral
2.5-10
mg/kg
 A potent
vasodilation
used to treat
energy
hypertension
condition
 It acts directly
on arterial &
venous smooth
muscle
 Decreases
peripheral
vascular
resistance .
 Improves
cardiac outputs
BP in
hypertoni
c crisis
Controlled
hypertens
ion in
surgical
procedure
Acute
CHF
Hypersens
itivity
Compensa
tory HTN
Increased
ICP
 Fleshing of
skin
 Increased
intracranial
pressure
 Rash
 Pain &
redness in
infection
site.
Monitor the
vital for
every ½
hourly
Monitor
cardiac
output
Cheek the
patient
infection site
for any
Pain redness
are present
or not
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 HYDRA
LAZINE
- Oral 0.75-1
mg
/kg/day
 An anti-
hypertensive
direct vaso
dilating effects
on bacterial
 Therapeutic
effect decreases
BP and systemic
resistance
Severe
hypertens
ion
Angina
Coronary
artery
disease
leepus
erythematou
s
 headache
 palpitation
 tachycardia
 nausea
 vomiting
 parenthesis
 fluid
cetertion
 peripheral
edema
 Dizziness
 Flushed face
 Nasal
congestion
Advise the
patient to
take the drug
meals
Notify
clinical of
any
unrespects
prolonged
general
tiredness or
fever muscle
or join
aching or
chest pain
Cheek the
stools
Advise
precaution
for
orthostatic
hypotension
ANTI LEPROSY
DRUGS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 DAPSO
NE
- Oral
1m
100mg
0.5ml/
0.2ml
 Bacteriostatic
activity
 It acts by
inhibiting the
de-noro
synthesis of
folic acid by
M.cepeai
 The action is
antagonist by
Para
aminodizolic
acid
Anti
lepeotic
uses
Dermatitis
Hypersens
itivity
Infant
younger
than
2months
 Hemolytic
anemia
 lever &
kidney
damage
 allergies
reaction
 nausea
 jaundice
 vomiting
 before
administrati
ng the drug
ask the
patient for
any allergic
reaction to
drug
 monitor 1/0
chart
 cheek for
any side
effects
ANTI-MALARIAL
DRUGS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 CHLOR
OQUINE
PHOSPH
ATE
ARAL
EN
Oral 10mg/
kg
 it is a 4 amino
quinolone
derivative
 it has a
suppressive
effect like
quinine
 it acts by
inhibiting the
incorporation
of phosphate
into RNA &
DNA of
plasmodia’s.
Acute
malaria
Extra
intestinal a
moebiasis
Giardiasis
Taeneasis
Arthritis
Hypersens
itivity
 Skin rashes
 Bleaching of
scalp, nose,
eye lashes
 Visual
distributes
 Blurred
vision
 Diplopia
 Psychotic
episodes
 Abdominal
cramps
 Anemia
Monitor
complete
blood count
Ensure that
periodic
visual or
ophthalmic
examination
are
performed
Monitor
lever
function test.
Check for
any side
effect
Check vital
signs
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 DRIM
AQUIN
EPHOS
PHAT
E
-
Oral 3mg/da
y
 It belongs to
the group of 8
aminoquinolines
 If acts on the
exocrytheocytes
cycle & on
ganeeto cycle
 Sonceof the
ganutocyteace
destroyed
 The remaining
cannot mature
in the mosquito
Malaria A granule
cytosols
Rheumatoi
d arthritis
 Nausea
 Vomiting
 Epigastric
disteriess
 Leukopenia
 Anemia
Guie the
drug by
follow 6
dights
Cause the
drug after
meals.
Obtain
frequent
blood studies
Cheek vital
signs
Cheek for
any side
effect
ANTI – T.B
DRUGS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATI
ON
CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 Pyrazina
mide
- Oral 20-30
mg/kg
body wt
is 3-4
divided
closed
max of
3 gm
daily
 It is the
pyrozine
analogue of
nuotinnude
 When the drug
is used alone the
diseases is
initially
contracted but
soonrelapses
because
microorganisms
rapidly resistant
 When it is
administered de
multineouslt
inoicazis the
bacteria is
sensitive.
Tuberculo
sis
Hypersens
itivity
 Aethealgeas
 Nausea
 Vomiting
 Dysuria
 Malaria
fever
 Elevation of
plasma uric
acid
 Acute
episodes of
gout.
Reduces serve
1NH
concentratio
n
Cheek vital
signs
Cheek for any
side effect
Observe cough
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
ROU
TE
DOSE MODE OF
ACTION
INDICATION CONTRAI
NDIRATI
ON
SIDE
EFFECT
NURSING
RESPONSIBIL
ITIES
2 ERYTH
ROMYC
IN
- Oral 250m
g/kg
 It mainly
acts on gram
+ve cocci
 It acts
against
penicillin
resistant
staphylococc
i.
URTI
Acute
pneumonia
Vaginitis
Impetigo
Wound &
burn
infection
Whooping
cough
Hypersens
itivity
 Mild to
sense
epigastria
pain
 Diarrhea
 Other
allergic
reactions
 May increases
serve digoxin
 Level so the
nurses should
be aware
about it.
 It reduces the
therapeutic
effect of
penicillin
terferadine &
astinizole
 It increases the
risk of the
adverse effect
on the heat so
cheek
continuously.
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
3 ETHA
MBUT
O
HYDR
OCHL
ORIDE
- Oral 15
mg/kg
 May inhibit
synthesis of on
or more
metabolites of
susceptible
bacteria
changing al
metabolism
during division.
Pulmon
ary TB
Children
younger than
13 years
hypersensitiv
ity
 headache
 optic
nutritive
 anemia
 nausea
 GF upset
 Joint paint.
Perform visual
aquity test &
Coloma that
before &
dividing
therapy.
Ensure any
change in
vision
Cheek any
other side
effects
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
4 ISONI
AZID
Isota
mine
Oral 10-15
mg/kg
 May inhibit all
wall
biosynthesis by
interfering rapid
& DNA
synthesis
Activity
growin
g
tubercl
e
bacilli.
Acute rap tie
disease
 Memory
impairment
 Hepatitis
 Jaundice
Always give
drug other
anti-tubercle
drug to
prevent
development
of resistance
Cheek for any
effect.
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
5 RIFAM
PICIN
- Oral/
IV
10-20
mg/kg
 Inhibit DNA
dependent RNA
polymerase
impairs RNA
synthesis
Pulmon
ary TB
Hypersensiti
vity
 Headache
 Fatigue
 Shock
 Drowsiness
 Hematuria
Give drug
atleast other
anti TB drug
for best
absorption
Monitor
hepatic
function
Give capsule 1
hour before
or 2 hrs after
meal.
Cheek for any
side effect
ANTI- VIRAL
DRUGS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICAT
ION
CONTRAI
NDIRATIO
N
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 ACYCL
OVIR
- Oral 10
mg/kg
 It inhibits the
replication of
virus
 It has a
selective effect
on the virus out
affecting the
host
 It is highly
effective against
reaps viruses
Neonatal
herpes
simplex
virus
infection
Herpes
zoster
virus
infection
Influenza
virus
infection
.
Hypersensi
tivity
Glaucoma
Depression
Pregnancy
Lactation
Penal
impairment
 Headache
 Nausea
 Vomiting
 Skin rash
 Vaginitis
 Alopecia
 Muscle
cramps
 Tremors
Do not give
1m/se
Monitor
mental
function
Tell patient to
take drug as
prescribed
Cheek for any
side effect
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICATIO
N
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 RIBAVI
RINE
- Oral/
IV
5-10
mg/kg
divided
dose
 It is a purine
nucleoside
analogue
 It Is a broad
spectrum of
antiviral
activity
against DNA
&RNA
viruses.
Infection
viral
infection
respiratory
tract viral
infection
influenza
virus
infection
viral
hepatitis
herpes group
of virus
hypersensiti
vity
anemia
renal
impairment
pregnancy
lactation
 headache
 nausea
 vomiting
 skin rash
 cardiac arrest
 HTN
Cheek vital
sigins
Follow 6
rights for
administerin
g the drug
Monitor renal
functions.
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
3 ZIDOV
UDINE
- Oral/
IV
2mg/kg  Nucleoside
reverse
transcriptase
inhibit
replication of
HIV of blocking
DNA synthesis
HIV
infectio
n
Hypersensiti
vity
Lactation
Pregnancy
 Nausea
 Vomiting
 Diarrhea
 Skin rash
 Headache
Monitor blood
studies
Cheek vital
signs
Instinct the
patient to
take drug is
in cepty
stomach
BRONCHO – DIALATORS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 ADREN
ALIZE
- IV/I
M
0.2-0.5
ml for
6hrs
 This is a patient
bronchodilator
 It also relieves
the pulmonary
congestion by
constricts the
pulmonary
arterioles
 The relief of an
attach of
adrenalin is
demotic but
may be
accompanied by
unpleasant
palpation
 It is helpful in
smooth muscle
relaxation.
Beady
cardio
Beady
arrhyth
mias
Hypersensiti
vity
Acute angle
closure
glaucoma
Ischemia
Obstructive
neuropathy
 Angina
 Nausea
 Headache
 Vomiting
 Sweating
Use extreme
caution in
alkylating &
preparing
doses
Any education
of adrenaline
that is turn to
pink should
not be given
BP should
cheek every
15 minutes
The drug
should be
injected
slowly.
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICAT
ION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 ATROPI
NE
SULHA
TE
- Oral/
IV
se
0.02-
0.15
mg/kg
 Anti-
cholinergic
that inhibits
acetyl choline
as pares ympa
their neuron
affect or
function
Brady
cardiac
Brady are
hythmias
Hypersensiti
vity
Acute angle
closure
glaucoma
Ischemia
Obstructive
uropathy
 Headache
 Insomnia
 Restlessness
 Palpitation
 Dey mouth
 Constipation
Cheek for
tacky cardiac
Cheek vital
signs
Monitor I/O
chart
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
3 IPRATR
OPIUM
BROMI
DE
- Inhal
ation
0.3%  It inhibits
reflux by
antagonizing
ACH muco
curaine
receptor on
bronchial
smooth muscle.
Broncho
spasm
Rhinorr
hea
Hypersensiti
ve
 Nausea
 Vomiting
 Blurred
vision
 Palpitation
 Chest pain
 GI distress
 dyspnea
take care to
purulent
leakage
around the
nose
the drug
should be
injected
slowly
cheek for any
side effects
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
4 SALBU
TAMOL
- Oral 1mg/kg
6-8 hrs
 it is an odorless
white powder
 it also relive
the pulmonary
congestion by
constricts the
pulmonary
arterioles
asthma
emphys
ema
bronchit
is
myocardial
insufficiency
hyperthyroid
ism
pregnancy
 palpitation
 tremors
 tachycardia
 anorexia
 vomiting
 nausea
cheek for any
side effect
monitor vital
signs
administer
drug by
follows 6
rights
CARDIOTONICS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 DIGOXI
N
- Orall
y /IV
10-
15mg/k
g
0.8-
1mg/kg
for loyr
children
 a cardiac
glycoside that
increases the
influx of cat
wine from
extracellular to
intracellular
cytoplasm
 it is
antiarrhythmic
cardiac
glycoside
CHF
Atrial
fibrillat
ion
Paroxys
m atrial
achy
cardiac
Ventricular
fibrillation
Hypersensiti
ve
Ventricular
tacky cardiac
Acute MI
Sinus beady
cardiac
Renal
disease
Hypothec
disease
 Fatigue
 Headache
 Malaria
 Arrhythmia
 Anorexia
 Nausea
 Vomiting
 Diarrhea
Do not
administer
rapidly by IV
route to
patient
receiving
diagnosis
Instant patient
do not take
an extra dose
of digoxin
Advise patient
to use some
beand
constantly
ANTI – NEOPLASTIC
DRUGS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATIO
N
CONTRAI
NDIRATIO
N
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 CYCL
OPHO
SPHA
MIDE
-
2-8
mg/
kg/
day
Oral/IV  An
alkylating
agent that
inhibits DNA
& RNA
protein
synthesis by
crossing
DNA & RNA
strands
 It preventing
cell growth.
 It is a potent
immune
suppressant
Nephrotic
syndrome
Hodgkin’s
disease
Mycosis
Fungoides
Retinoblasto
ma
Breast
carcinoma
Ovarian
adenocarci
noma
Hypersensi
tivity
Bone
marrow
suppresses
Impaired
renal/replica
function
Leukopenia
Nausea
Vomiting
Alopecia
Diarrhea
Darkening of
skin
Stomatitis
Headache
Diaphoresis
Monitoring
CBC,
differential,
platelet
count
Renal function
studies,
BUN.UA,
serum, uric
acid
Take the input
output
report.
SL
NO
.
NAME
OF
DRUG
TRA
DE
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATIO
N
CONTRAI
NDIRATIO
N
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 VINCR
ISTINE
SULFA
TE
- IV 1.4-2
mg/day
>10kg
50mg/k
g for
once
weekly
 It exceeds it
cytotoxic
activity by
assessing the
cell lysis is
the metap
bone protein
of cell
division
resulting cell
lysis
 Also inhibits
DNA
dependent,
RNA
synthesis
Hodgkin
disease
Neuronblast
oma
Willm’s
tumor
Hypersensi
tivity
Hepatic
dysfunction
Sensory loss
Loss of deep
tendon
reflexes
Diplopia
Diarrhea
Constipation
Nausea
Vomiting
Anoxia
Weight loss
Encourage
adequate
fluid intake
to increase
urine output
SL
NO
.
NAME
OF
DRUG
TRA
DE
NA
ME
ROU
TE
DOSE MODE OF
ACTION
INDICATIO
N
CONTRAI
NDIRATIO
N
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
3 METH
OTRE
XATE
- Oral /
IV
10-15
mg/day
 An anti
metabolite
that competes
enzymes
necessary to
reduce folic
acid to tetra
hydro folic
acid.
 It causes
death of
cancer cells.
Trophoblasti
c neoplasm
Notify
Head &
neck cancer
Chariot
carcinoma
Acute
lymphocyti
c leukemia
Rheumatic
arthritis
Psoriasis
Lymph
sarcoma
Hypersensi
tivity
Hepatic
dysfunction
Nausea
Vomiting
Stomatitis
Burning
Erythema
Diarrhea
Rash
Dermatitis
Provirus
Dizziness
Alopecia
Anorexia
Malaria
Headache
Blurred
vission
Provide
patient
fanuly
education
Notify
clinician of
black, chills,
fever, sere
throat,
bleeding
Diet 10-12
glasses of
fluid/day
Assess lives
function tests
ANTI – RETROVIRAL
DRUGS
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
1 INDIN
AVIR
SULFA
TE
Crixi
van
500
mg
Oral  It prevents
cleavage of the
viral ply protein
by bindings to
the protease
active site
leading from
action of
immature non-
infections viral
particles.
HIV
infectio
n
Hypersensiti
ve
Sever
hepatic
impairment
Headache
Malaria
Insomnia
Dizziness
Abdominal
pain
Nausea
Vomiting
Back pain
Insect the
patient to
drink at least
1.5 L of
fluid daily
Inform the
patient that
indinavir is
not a cure for
HIV
infection
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
2 ZIDOV
UDINE
- 160
mg
up to
200
mg/k
g for
neon
ate
Oral  It will prevents
the cleavage of
the vital poly
proteins by
binding to the
protease active
site
HIV
infectio
ns
Hypersensiti
ve
Diarrhea
Acid
regulation
Dry mouth
Flank pain
Severe
headache
Dizziness
Convulsions
Instruct the
patient to
drink at least
1.5 L of fluid
daily
SL
NO
.
NAME
OF
DRUG
TRA
DE
NAM
E
RO
UTE
DOSE MODE OF
ACTION
INDICA
TION
CONTRAIN
DIRATION
SIDE
EFFECT
NURSING
RESPONSIBI
LITIES
3 AZIDOT
HYMIDI
NE
- Oral/
IV
200-250
mg
every 4-
8 hrs.
 It is synthetic
analogue of
thymidine
 It acts by
inhibiting viral
transcriptase
 It crosses
placenta
 It decreases
mortality
HIV
infectio
n
Hypersensiti
vity
 Diarrhea
 Nausea
 Vomiting
 Dizziness
 Convulsions
Instruct the
patient to
drink al least
1.5 L of fluid
daily
Cheek for side
effects
Monitor
continuously

More Related Content

Similar to drug book.docx

Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
Dr. Siddhartha Dutta
 
cocogenetics.pdf
cocogenetics.pdfcocogenetics.pdf
cocogenetics.pdf
PrincessYumi2
 
Seretonin and Its Antagonists.pptx
Seretonin and Its Antagonists.pptxSeretonin and Its Antagonists.pptx
Seretonin and Its Antagonists.pptx
anupjagarlamudi1
 
Sulfonamides(1)
Sulfonamides(1)Sulfonamides(1)
Sulfonamides(1)
Muhammad Imran
 
Principle Drug Use.pptx
Principle Drug Use.pptxPrinciple Drug Use.pptx
Principle Drug Use.pptx
ssuser6bee05
 
Autonomics Parasympathetic
Autonomics ParasympatheticAutonomics Parasympathetic
Autonomics Parasympathetic
MD Specialclass
 
Autonomics Parasympathetic
Autonomics ParasympatheticAutonomics Parasympathetic
Autonomics Parasympathetic
MD Specialclass
 
HYDROCORTISONE INJECTION
HYDROCORTISONE INJECTIONHYDROCORTISONE INJECTION
HYDROCORTISONE INJECTION
KAVIYA AP
 
study of chf (congestive heart failure) made easy with the help of resent cas...
study of chf (congestive heart failure) made easy with the help of resent cas...study of chf (congestive heart failure) made easy with the help of resent cas...
study of chf (congestive heart failure) made easy with the help of resent cas...
AkshayDeshmukh780714
 
Drug interactions and monitoring drug therapy satya
Drug interactions and monitoring drug therapy satyaDrug interactions and monitoring drug therapy satya
Drug interactions and monitoring drug therapy satya
sathyanarayanan varadarajan
 
Psychopharmacology-copy.pptx
Psychopharmacology-copy.pptxPsychopharmacology-copy.pptx
Psychopharmacology-copy.pptx
DexterNicolas2
 
101416471 drugs-case-study-respi
101416471 drugs-case-study-respi101416471 drugs-case-study-respi
101416471 drugs-case-study-respi
homeworkping7
 
Anti tubercular drugs
Anti tubercular drugsAnti tubercular drugs
Anti tubercular drugs
Koppala RVS Chaitanya
 
Factors modifying drug action
 Factors modifying drug action  Factors modifying drug action
Factors modifying drug action
Manoj Kumar
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
Jyoti Sharma
 
Guide1
Guide1Guide1
Guide1
dareseking
 
ANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptxANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptx
SmrutirekhaParida1
 
N Acetylcysteine
N AcetylcysteineN Acetylcysteine
N Acetylcysteine
Trennette Gilbert
 
Rifampicin
RifampicinRifampicin
Rifampicin
Duraid Khalid
 
Mannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptxMannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptx
Rachel O
 

Similar to drug book.docx (20)

Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
cocogenetics.pdf
cocogenetics.pdfcocogenetics.pdf
cocogenetics.pdf
 
Seretonin and Its Antagonists.pptx
Seretonin and Its Antagonists.pptxSeretonin and Its Antagonists.pptx
Seretonin and Its Antagonists.pptx
 
Sulfonamides(1)
Sulfonamides(1)Sulfonamides(1)
Sulfonamides(1)
 
Principle Drug Use.pptx
Principle Drug Use.pptxPrinciple Drug Use.pptx
Principle Drug Use.pptx
 
Autonomics Parasympathetic
Autonomics ParasympatheticAutonomics Parasympathetic
Autonomics Parasympathetic
 
Autonomics Parasympathetic
Autonomics ParasympatheticAutonomics Parasympathetic
Autonomics Parasympathetic
 
HYDROCORTISONE INJECTION
HYDROCORTISONE INJECTIONHYDROCORTISONE INJECTION
HYDROCORTISONE INJECTION
 
study of chf (congestive heart failure) made easy with the help of resent cas...
study of chf (congestive heart failure) made easy with the help of resent cas...study of chf (congestive heart failure) made easy with the help of resent cas...
study of chf (congestive heart failure) made easy with the help of resent cas...
 
Drug interactions and monitoring drug therapy satya
Drug interactions and monitoring drug therapy satyaDrug interactions and monitoring drug therapy satya
Drug interactions and monitoring drug therapy satya
 
Psychopharmacology-copy.pptx
Psychopharmacology-copy.pptxPsychopharmacology-copy.pptx
Psychopharmacology-copy.pptx
 
101416471 drugs-case-study-respi
101416471 drugs-case-study-respi101416471 drugs-case-study-respi
101416471 drugs-case-study-respi
 
Anti tubercular drugs
Anti tubercular drugsAnti tubercular drugs
Anti tubercular drugs
 
Factors modifying drug action
 Factors modifying drug action  Factors modifying drug action
Factors modifying drug action
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
 
Guide1
Guide1Guide1
Guide1
 
ANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptxANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptx
 
N Acetylcysteine
N AcetylcysteineN Acetylcysteine
N Acetylcysteine
 
Rifampicin
RifampicinRifampicin
Rifampicin
 
Mannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptxMannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptx
 

Recently uploaded

Accounting for Restricted Grants When and How To Record Properly
Accounting for Restricted Grants  When and How To Record ProperlyAccounting for Restricted Grants  When and How To Record Properly
Accounting for Restricted Grants When and How To Record Properly
TechSoup
 
Data Structure using C by Dr. K Adisesha .ppsx
Data Structure using C by Dr. K Adisesha .ppsxData Structure using C by Dr. K Adisesha .ppsx
Data Structure using C by Dr. K Adisesha .ppsx
Prof. Dr. K. Adisesha
 
A Free 200-Page eBook ~ Brain and Mind Exercise.pptx
A Free 200-Page eBook ~ Brain and Mind Exercise.pptxA Free 200-Page eBook ~ Brain and Mind Exercise.pptx
A Free 200-Page eBook ~ Brain and Mind Exercise.pptx
OH TEIK BIN
 
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
EduSkills OECD
 
220711130088 Sumi Basak Virtual University EPC 3.pptx
220711130088 Sumi Basak Virtual University EPC 3.pptx220711130088 Sumi Basak Virtual University EPC 3.pptx
220711130088 Sumi Basak Virtual University EPC 3.pptx
Kalna College
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
Jyoti Chand
 
BPSC-105 important questions for june term end exam
BPSC-105 important questions for june term end examBPSC-105 important questions for june term end exam
BPSC-105 important questions for june term end exam
sonukumargpnirsadhan
 
skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)
Mohammad Al-Dhahabi
 
78 Microsoft-Publisher - Sirin Sultana Bora.pptx
78 Microsoft-Publisher - Sirin Sultana Bora.pptx78 Microsoft-Publisher - Sirin Sultana Bora.pptx
78 Microsoft-Publisher - Sirin Sultana Bora.pptx
Kalna College
 
Educational Technology in the Health Sciences
Educational Technology in the Health SciencesEducational Technology in the Health Sciences
Educational Technology in the Health Sciences
Iris Thiele Isip-Tan
 
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptxBIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
RidwanHassanYusuf
 
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
indexPub
 
NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...
NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...
NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...
Payaamvohra1
 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
danielkiash986
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
Steve Thomason
 
How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17
Celine George
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
haiqairshad
 
Bonku-Babus-Friend by Sathyajith Ray (9)
Bonku-Babus-Friend by Sathyajith Ray  (9)Bonku-Babus-Friend by Sathyajith Ray  (9)
Bonku-Babus-Friend by Sathyajith Ray (9)
nitinpv4ai
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
khuleseema60
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
deepaannamalai16
 

Recently uploaded (20)

Accounting for Restricted Grants When and How To Record Properly
Accounting for Restricted Grants  When and How To Record ProperlyAccounting for Restricted Grants  When and How To Record Properly
Accounting for Restricted Grants When and How To Record Properly
 
Data Structure using C by Dr. K Adisesha .ppsx
Data Structure using C by Dr. K Adisesha .ppsxData Structure using C by Dr. K Adisesha .ppsx
Data Structure using C by Dr. K Adisesha .ppsx
 
A Free 200-Page eBook ~ Brain and Mind Exercise.pptx
A Free 200-Page eBook ~ Brain and Mind Exercise.pptxA Free 200-Page eBook ~ Brain and Mind Exercise.pptx
A Free 200-Page eBook ~ Brain and Mind Exercise.pptx
 
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
 
220711130088 Sumi Basak Virtual University EPC 3.pptx
220711130088 Sumi Basak Virtual University EPC 3.pptx220711130088 Sumi Basak Virtual University EPC 3.pptx
220711130088 Sumi Basak Virtual University EPC 3.pptx
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
 
BPSC-105 important questions for june term end exam
BPSC-105 important questions for june term end examBPSC-105 important questions for june term end exam
BPSC-105 important questions for june term end exam
 
skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)
 
78 Microsoft-Publisher - Sirin Sultana Bora.pptx
78 Microsoft-Publisher - Sirin Sultana Bora.pptx78 Microsoft-Publisher - Sirin Sultana Bora.pptx
78 Microsoft-Publisher - Sirin Sultana Bora.pptx
 
Educational Technology in the Health Sciences
Educational Technology in the Health SciencesEducational Technology in the Health Sciences
Educational Technology in the Health Sciences
 
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptxBIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
 
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
 
NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...
NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...
NIPER 2024 MEMORY BASED QUESTIONS.ANSWERS TO NIPER 2024 QUESTIONS.NIPER JEE 2...
 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
 
How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
 
Bonku-Babus-Friend by Sathyajith Ray (9)
Bonku-Babus-Friend by Sathyajith Ray  (9)Bonku-Babus-Friend by Sathyajith Ray  (9)
Bonku-Babus-Friend by Sathyajith Ray (9)
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
 

drug book.docx

  • 1. DRUG BOOK SIGNATURE OF SUBJECT COORDINATOR SIGNATURE OF EXTERNAL SIGNATURE OF INTERNAL
  • 3. SR.NO NAME OR CLASSIFICATIONS NAME OF THE DUG 1 ANALGESICS AND ANESTHETICS  ACETAMINOHEN  ASPIRIN  FENTANYL  IBUPROFEN  KETAMINE  MIDAZOLAM  PROPOFOL 2 ANTICONVULSANTS  PHENYTOIN  PHENO BARBITOL  SODIUM VALPROATE  CARBOMAZEPINE 3 ANTI COAGULANTS  HEPARIN  WARFARIN
  • 4. 4 ANTIHYPERTENSIVE  ATENDOL  PROPRANOLAL  NEFEDIPINE  VERAPAMIL 5 DIURETICS  ACETAZOLAMIDE  FRUZEMIDE  MANNITOL  SPIRANOLACTONE 6 VASODILATORS  SODIUM NITROPRUSSIDE  HYDRALAZINE 7 ANTI TUBERCULOSIS DRUGS  ISONIAZID  PYRAZINAMIDE  RIFAMPICIN  ERYTHROMYCIN
  • 5. 8 ANTI LEPROSY DRUGS  DAPSON 9 BROCHO DILATORS  SALBUTAMOL  ATROPINE SULPHATE  TERBUTALINE 10 ANTI MALARIAL DRUGS  CHLOROQUININE PHOSPHATE  PRIMAQUININE PHOSPHATE 11 ANTIVIRALS  ACYLOVIR  RIBOVIRIN  ZIDOVUDINE 12 CARDIOTONICS  DGOXIN
  • 6. 13 ANTI BIOTICS  AMPICILLIN  PENCILLIN  TETRACYCLIN HYDROCHLORIDE  CEFOTAXIM 14 ANTI RETROVIRALS  INOINAVIR SULPHATE  ZINDOVUDINE 15 ANTI NEOPLASTIC DRUGS  CYCLO PHOSPHAMIDE  VINCRISTINE SULPHATE
  • 8. SL NO. NAME OF DRUG TRADE NAME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAINDI RATION SIDE EFFECT NURSING RESPONSI BILITIES 1 ACET AMIN OPHE N AASE AEGI NA ORA L 300M g  It exhibits analysis action by peripheral blockage of pain impulse generation  It produces antipyretics effect by inhibiting the hypothalam ic heart regulation center.  Mild, moderate pain  Post impyrexi a  Rheumat ic fever  Hypersensiti vity  Nausea  Vomiting  Allergic reaction  Skin rashes  Diarrhea  Ulceration  Perforatio n  Hemaehag e  Neurosis  Aplastic anemia  Check for any C.I  Check for any adverse reaction.  Follow the principle s of drug administr ation.
  • 9. 2 aspirin Arced Oral 3-25 mg 80- 100- mg/kg  It inhibits analgesic action by antipyretic action  A non- steroidal salicylate that inhibits prosta glandins synthesis acts on the hypothalam us heart regulating center.  A substance that stimulate platelet aggregates.  It reduces inflammatio n, pain, decreases fever. Analgesia Fever MI Stroke Ischemic attack Kawasaki disease Hypersensitivi ty Bleeding disorders Chicken ox GI bleeding o ulceration Hepatic impairment Allergy Pregnancy lactation  GI distress  Allergic reaction  Bronchospa sm  Pursuits  Urticaria  Headache  Tinnitus  Difficulty in hearing  Lethargy  Confusion  Drowsiness’ Use liquid form for children & patient who are difficulty in swallowing In children don’t exceeds five dos in 24hrs Check vital signs Chick for any rashes
  • 10. SL NO. NAME OF DRUG TRAD E NAME ROUTE DOSE MODE OF ACTION INDICA TION CONTRAIND IRATION SIDE EFFECT NURSING RESPONSI BILITIES 3 IBUPR OFEN - 8-12mg 600-8— mg 0.4- 0.6gm Iv Oral  It Is a synthetic compound having analgesic & mid anti- inflammatory effect  Fever  pain a cute peptic ulcer gastric irritation dyspnea GI bleeding jaundice  check for side effects
  • 11. SL NO. NAME OF DRUG TRAD E NAME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATIO N SIDE EFFECT NURSING RESPONSI BILITIES 4 FENT ANYL fend cap O IV 0.5- 3mg/kg 0.5- 1mg/kg  it inhibits prostaglandi n synthesis  pain  anesthesia hypersensit ivity dyspnea peptic ulcer rhinitis nausea vomiting  check for any side effect & adverse reaction  assess vital signs regularly
  • 12. SL NO. NAME OF DRUG TRAD E NAME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATIO N SIDE EFFECT NURSING RESPONSI BILITIES 5 PROP OFOL - IV 1- 2mgl/kg It Is an liquid used as 1% emulsion. It is used for i.v indication & short duration anesthesia.  Sedation  ECT hypersensit ivity nausea vomiting pain headache involuntary muscle contraction  check for any side effect  monitor vital signs
  • 14. SL NO. NAME OF DRUG TRAD E NAME ROU TE DOSE MODE OF ACTION INDICAT ION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSI BILITIES 1 PHEN YTOIN EPTOI N Oral 5 mg/kg May stabilize neuronal and limit seizure activity either by increasing influx of ion across the cell membrane is to monitor cortex of nerve impulse Tonic clone seizure  Static epilepti cs Hypersensiti vity Hepatic dysfunctio n Hypotension Respiratory depression Ataxia Diplopia Vomiting Constipation Toxichepatit es  don’tgive IM unless dosage adjustment  Divided dosegive with or after meal.  Don’t stop drug suddenly  Monitor drug level.
  • 15. SL NO. NAME OF DRUG TRAD E NAME ROUTE DOSE MODE OF ACTION INDICAT ION CONTRAIND IRATION SIDE EFFECT NURSING RESPONSI BILITIES 2 Sodium valproa te - Oral/IV 10-15 mg/kg Unknown facilitated the effects to inhibit neuron transmitter GABA  Sample complex seizure  Mixed seizure type Hypersen situity Hepatic disease Children younger than 10years Urea cycle disorders Dizziness Headache Insomnia Chest pain Hypertensio n Blurred vision Abdominal pain Anorexia Diarrhea Alopecia  Obtain lives function test  Monitor drug level  Tell patient to take drug c food/milk to reduce and verse GJ effect.
  • 16. SL NO. NAME OF DRUG TRA DE NAM E ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAIND IRATION SIDE EFFECT NURSING RESPONSI BILITIES 3 Diaz epam - IV/IM oral 0.12- 0.8 mg/kg/ day 0.04- 0.3 mg/kg  A benzodiazepin e that depresses all levels of the CNS by enhancing the action of gamma amino butyric acid, a major inhibitory neurotransmitt er in the brain  It produces anxiolytic effect, elevates the seizure threshold Cough Anxiety Skeletal muscle relaxation Preanesthe sia Alcohol arthdeval Status epileptics Hypersensitiv ity Angle closure glaucoma Coma CNS depression Respiratory depression Sever uncontrolled pain Pain IM injection Somnolenc e Fatigue Ataxia Slurred speech Headache Constipatio n Nausea Blurred vision  When the patient have sudden change of position can cause of zziness  In street the patient to avoid alcohol while taking diazepam  Monitor vital signs.
  • 18. SL NO . NAME OF DRUG TR AD E NA ME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAIND IRATION SIDE EFFECT NURSING RESPONSI BILITIES 1 AMPICI LLIN - ORAL /IV 25- 30mg/k g  Inhibit cell- wall synthesis during bacterial multiplication. UTI G1 infection Skin infection Hypersensitiv ity Seizure Lethargy Vomiting Diarrhea Nausea Anaxity Confusion Before giving drug ask Pt about degree of reaction to penicillin Monitor Na+ level
  • 19. SL NO . NAME OF DRUG TR AD E NA ME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 2 Penicil lin - IV/1m l oral 500mg  It is bind to the bacterial cell wall synthesis.  The protects the penicillin from enzymatic degradation. Respirator y infection UTI Meningoc occal infection hypersensiti vity seizure diarrhea nausea vomiting headache oral or vaginal candidiasis anemia monitor the patients pulse & B.P notify the vomiting or diarrhea monitor respiratory rate& any rashes Cheek for any side effect.
  • 20. SL NO . NAME OF DRUG TRA DE NAM E ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAIND IRATION SIDE EFFECT NURSING RESPONSI BILITIES 3 AMIKA CIN Amik in IV/IM 250 mg for 12hrs  It is an aminoglycoside antibiotic that irreversibly binds to protein or bacterial ribosomes.  Interferes protein synthesis of susceptible microorganism Typhoid Bronchitis UTI Hypersensitiv ity Pain in duration Thromboph lebitis Difficulty in breathing Drowsiness Weakness  Monitor patient for swelling  Monitor respiratory rate.  Monitor urine output  Monitor the patient pulse & B.P 
  • 21. SL NO . NAME OF DRUG TR AD E NA ME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAIND IRATION SIDE EFFECT NURSING RESPONSI BILITIES 4 TETRAC YCLIC HYDRO CHLOID E - Oral 25- 30mg/k g  May exert bacteriostatic effect by binding to protein or bacterial ribosomes.  They inhibit protein synthesis. Grana positive infections Rectal infection n Urethral & endo- cervical infection Soretheoat Glossites Diarrhea Hypersensitiv ity Nausea Vomiting Skin rashes Obtain specimen for culture & sensitivity. Check patient tongue for infection Check for any side effect
  • 23. SL NO . NAME OF DRUG TR AD E NA ME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAIND IRATION SIDE EFFECT NURSING RESPONSI BILITIES 1 HEARIN - IV 25- 50units /kg hr  Accelerator reaction of anti-thrombin complex and deactivates thrombin preventing of fibrinogen to fibrin. Pulmonary embolism Deseirited intravascu lar coagulati on. Hypersensitiv ity Active bleeding Ascorbic acid deficiency Fever Rhinitis Irritation Peuritis Cut Icaria Dew blood to establishes baseline coagulatio n before therapy . Check vital
  • 26. SL NO . NAME OF DRUG TRA DE NAM E ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 1 Epineph rine - 1m, sc IV 0.2- 0.5 ml 0.25m g  It has stimulant action on predominant B receptor  It dilates the blood vessels of the skeletal muscle on account of predocinderent of B2 receptor.  It increases heart rate & myocardial contractility. Anaphylac tic shock Bronchial asthma Cardiac resusutati on Open angle gleeman Angoneur otic edema of larynx Vertigo hypotensio n Hypotension Palpation Angina Nausea Headache Vomiting Sweating  Use extrence caution in alkylate & preparing doses  Any solution of adrenaline that is teen to panic should not be given.  Bp should be cheeked energy 15minuts.
  • 27. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 2 Propran olol - Oral 0.5- 1mg/k g/day  An anti- hypertensive, antianginal, antiarrhythmic, & ant migraine agent that blocks beta1,beta2, adrenergic receptors.  It decreases oxygen requirements.  It slows Av conduction.  Therapeutic effect: decreases cardiac out put Angina Arrhythmi c Hypertrop hy sub aortic stenosis. Migraine headache MI Essential tremors Asthenia Beady card Cardiogen ic shock Raynaud & syndrome CHF Pregnancy Lactation  Diminished sexual ability  Drowsiness  Difficulty sleeping  Unusual fatigue  Beady cardiac  Depression  Diarrhea  Anxiety  Pruritus  Always cheek patents apical pulse before giving drug.  Pulse rate occurs a rolel drug & notify pees cubes incredibly  Give drug consistently meals foods. May increase absorption of propranolol
  • 28. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 3 AMLO DIPINE - oral 5- 10mg It has antianginal antihypertensive actor A calcium channel blockers that inhibits ca moucment across cardiac &vascular smooth cell membrane. Therapeutic effect decreases peripheral vascular resistance & BP by vasodilation. Hypertensi on Angina Renal inepairien t Hyper sensitivity Severe hypotension Aortic stenosis Heart failure Severe hepatic diseases  Peripheral edema  Headache  Flushing  Dizziness  Palpitation  Nausea  Fatigue  Chest pain  Beady cardia  Orthostatic hypotension  Tel the patient to take nitroglycerine for acute angina symptoms.  Notify cline of irregular heartbeat, shortness of breath, shortness of breath , swelling of feet, hand etc.  Monitor BP continuously.
  • 29. SL NO . NAME OF DRUG TRAD E NAME ROU TE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 4 HYDR ALAZI NE - Oral/ IV 0.75- 1mg/k g/day  An anti- hypertensive direct vasodilating effects on arterials.  Therapeutic effect: decreases BP & resistance. Hypertensi on Failure of heart Hypersens itivity Coronary artery disease CNA Renal caiemant  Headache  Palpitation  Tachycardi a  GI disturbances  Nausea  Vomiting  Peripheral ederea  Dizziness  Nasal congestion  Flushed face CBC, left cell purparation & ANA litxe diter mination should be performed before surgery Advise precaution from orthostatic hypotension. For IV use monitor BP every 5minutes
  • 31. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 1 FUOSE MIDE - Oral/ IV/ IM 1- 6mg/kg day in 6-12 hr 1-2 mg/kg (IV,IM)  Aldop duretic that enhances excretion of sodium chloride & potassium by direct action at the ascending liner of the loop of Henley  It produces decrees & lower BP Edema Hypertensi on Anuria Hepatic coma Sever electrolyte depletion Pregnancy lactation  increased urinary frequency  nausea  dyspepsia  abdominal camps  diarrhea  constipation  electrolyte disturbance  dizziness  to prevent nocturia give PO&IM preparation on the morning  monitor fluid intake & output electrolytes, BUN & co2 level frequency  watch for s/s of hypokalemia  monitor glucose level in DM patient
  • 32. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 2 SPIRON OLACT ONE - PO 1.5-3.3 mg/kg/d ay in 1- 2 divided doses  an potassium sparing durative that intefeve sodium reabsorption by competitively inhibiting the action of aldosterone in the distal tubule, this promoting Na & H2o excretive &  it produce diuresis lower BP edema hypertensi on hirsutine mypolcale nier primacy aldostero ne acute renal insufficienc y anuria BUN & serum creatin level increase Hyperkale mia Pregnancy Lactation  Hypertension  dehydration  nausea  lethargy  dyspepsia  abdominal camps  diarrhea  constipation  confusion Assess the patent actually Monitor vital signs Cheek for any rashes Cheek for abdominal discomfort Give the drug meals to enhance the absorption Instruct the patient to report mental confusion
  • 33. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 3 TRIAM TEREN E - Oral 2-4 mg/kg/d ay in single dose  A potassium sparing directive that inhibits sodium, potassium ATPase  It increases odium & decreases potassium excretion  It produces decreases & lowers BP Edema Hypertensi on Hyperkale mia Renal disease Hepatic disease Pregnancy lactation  fatigue  nausea  diarrhea  abdominal pain  leg cramps  headache  anorexia  rash  dizziness  ECG changes Assess the patient actually Monitor vital signs Cheek for any rashes Monitor ECG Monitor BUN & creatin level Cheek for fluid electrolyte imbalance
  • 34. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 4 XIPAMI DE - Oral 10- 20mg  It is peniacysite of action is the cortical segment of early distal tubes.  If inhibit sodium reabsorption, choice & water are retained in the tubule secondly  Relaxant effect on arterioles & elevation of blood. Edema Hepatic crepauien t Renal crepavierien t Acute electrolyte unbalance Cirrhosis of lives  Weakness  Fatigue  Muscle camp  GI disturbance  Hearing loss Monitor vital signs Monitor patient for allergic reaction Monitor to chart Provide right dosage at right time.
  • 36. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 1 SODIUM NITROP RUSSID E - IV/ oral 2.5-10 mg/kg  A potent vasodilation used to treat energy hypertension condition  It acts directly on arterial & venous smooth muscle  Decreases peripheral vascular resistance .  Improves cardiac outputs BP in hypertoni c crisis Controlled hypertens ion in surgical procedure Acute CHF Hypersens itivity Compensa tory HTN Increased ICP  Fleshing of skin  Increased intracranial pressure  Rash  Pain & redness in infection site. Monitor the vital for every ½ hourly Monitor cardiac output Cheek the patient infection site for any Pain redness are present or not
  • 37. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 2 HYDRA LAZINE - Oral 0.75-1 mg /kg/day  An anti- hypertensive direct vaso dilating effects on bacterial  Therapeutic effect decreases BP and systemic resistance Severe hypertens ion Angina Coronary artery disease leepus erythematou s  headache  palpitation  tachycardia  nausea  vomiting  parenthesis  fluid cetertion  peripheral edema  Dizziness  Flushed face  Nasal congestion Advise the patient to take the drug meals Notify clinical of any unrespects prolonged general tiredness or fever muscle or join aching or chest pain Cheek the stools Advise precaution for orthostatic hypotension
  • 39. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 1 DAPSO NE - Oral 1m 100mg 0.5ml/ 0.2ml  Bacteriostatic activity  It acts by inhibiting the de-noro synthesis of folic acid by M.cepeai  The action is antagonist by Para aminodizolic acid Anti lepeotic uses Dermatitis Hypersens itivity Infant younger than 2months  Hemolytic anemia  lever & kidney damage  allergies reaction  nausea  jaundice  vomiting  before administrati ng the drug ask the patient for any allergic reaction to drug  monitor 1/0 chart  cheek for any side effects
  • 41. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 1 CHLOR OQUINE PHOSPH ATE ARAL EN Oral 10mg/ kg  it is a 4 amino quinolone derivative  it has a suppressive effect like quinine  it acts by inhibiting the incorporation of phosphate into RNA & DNA of plasmodia’s. Acute malaria Extra intestinal a moebiasis Giardiasis Taeneasis Arthritis Hypersens itivity  Skin rashes  Bleaching of scalp, nose, eye lashes  Visual distributes  Blurred vision  Diplopia  Psychotic episodes  Abdominal cramps  Anemia Monitor complete blood count Ensure that periodic visual or ophthalmic examination are performed Monitor lever function test. Check for any side effect Check vital signs
  • 42. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 2 DRIM AQUIN EPHOS PHAT E - Oral 3mg/da y  It belongs to the group of 8 aminoquinolines  If acts on the exocrytheocytes cycle & on ganeeto cycle  Sonceof the ganutocyteace destroyed  The remaining cannot mature in the mosquito Malaria A granule cytosols Rheumatoi d arthritis  Nausea  Vomiting  Epigastric disteriess  Leukopenia  Anemia Guie the drug by follow 6 dights Cause the drug after meals. Obtain frequent blood studies Cheek vital signs Cheek for any side effect
  • 44. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATI ON CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBI LITIES 1 Pyrazina mide - Oral 20-30 mg/kg body wt is 3-4 divided closed max of 3 gm daily  It is the pyrozine analogue of nuotinnude  When the drug is used alone the diseases is initially contracted but soonrelapses because microorganisms rapidly resistant  When it is administered de multineouslt inoicazis the bacteria is sensitive. Tuberculo sis Hypersens itivity  Aethealgeas  Nausea  Vomiting  Dysuria  Malaria fever  Elevation of plasma uric acid  Acute episodes of gout. Reduces serve 1NH concentratio n Cheek vital signs Cheek for any side effect Observe cough
  • 45. SL NO . NAME OF DRUG TRA DE NAM E ROU TE DOSE MODE OF ACTION INDICATION CONTRAI NDIRATI ON SIDE EFFECT NURSING RESPONSIBIL ITIES 2 ERYTH ROMYC IN - Oral 250m g/kg  It mainly acts on gram +ve cocci  It acts against penicillin resistant staphylococc i. URTI Acute pneumonia Vaginitis Impetigo Wound & burn infection Whooping cough Hypersens itivity  Mild to sense epigastria pain  Diarrhea  Other allergic reactions  May increases serve digoxin  Level so the nurses should be aware about it.  It reduces the therapeutic effect of penicillin terferadine & astinizole  It increases the risk of the adverse effect on the heat so cheek continuously.
  • 46. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 3 ETHA MBUT O HYDR OCHL ORIDE - Oral 15 mg/kg  May inhibit synthesis of on or more metabolites of susceptible bacteria changing al metabolism during division. Pulmon ary TB Children younger than 13 years hypersensitiv ity  headache  optic nutritive  anemia  nausea  GF upset  Joint paint. Perform visual aquity test & Coloma that before & dividing therapy. Ensure any change in vision Cheek any other side effects
  • 47. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 4 ISONI AZID Isota mine Oral 10-15 mg/kg  May inhibit all wall biosynthesis by interfering rapid & DNA synthesis Activity growin g tubercl e bacilli. Acute rap tie disease  Memory impairment  Hepatitis  Jaundice Always give drug other anti-tubercle drug to prevent development of resistance Cheek for any effect.
  • 48. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 5 RIFAM PICIN - Oral/ IV 10-20 mg/kg  Inhibit DNA dependent RNA polymerase impairs RNA synthesis Pulmon ary TB Hypersensiti vity  Headache  Fatigue  Shock  Drowsiness  Hematuria Give drug atleast other anti TB drug for best absorption Monitor hepatic function Give capsule 1 hour before or 2 hrs after meal. Cheek for any side effect
  • 50. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICAT ION CONTRAI NDIRATIO N SIDE EFFECT NURSING RESPONSIBI LITIES 1 ACYCL OVIR - Oral 10 mg/kg  It inhibits the replication of virus  It has a selective effect on the virus out affecting the host  It is highly effective against reaps viruses Neonatal herpes simplex virus infection Herpes zoster virus infection Influenza virus infection . Hypersensi tivity Glaucoma Depression Pregnancy Lactation Penal impairment  Headache  Nausea  Vomiting  Skin rash  Vaginitis  Alopecia  Muscle cramps  Tremors Do not give 1m/se Monitor mental function Tell patient to take drug as prescribed Cheek for any side effect
  • 51. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICATIO N CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 2 RIBAVI RINE - Oral/ IV 5-10 mg/kg divided dose  It is a purine nucleoside analogue  It Is a broad spectrum of antiviral activity against DNA &RNA viruses. Infection viral infection respiratory tract viral infection influenza virus infection viral hepatitis herpes group of virus hypersensiti vity anemia renal impairment pregnancy lactation  headache  nausea  vomiting  skin rash  cardiac arrest  HTN Cheek vital sigins Follow 6 rights for administerin g the drug Monitor renal functions.
  • 52. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 3 ZIDOV UDINE - Oral/ IV 2mg/kg  Nucleoside reverse transcriptase inhibit replication of HIV of blocking DNA synthesis HIV infectio n Hypersensiti vity Lactation Pregnancy  Nausea  Vomiting  Diarrhea  Skin rash  Headache Monitor blood studies Cheek vital signs Instinct the patient to take drug is in cepty stomach
  • 54. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 1 ADREN ALIZE - IV/I M 0.2-0.5 ml for 6hrs  This is a patient bronchodilator  It also relieves the pulmonary congestion by constricts the pulmonary arterioles  The relief of an attach of adrenalin is demotic but may be accompanied by unpleasant palpation  It is helpful in smooth muscle relaxation. Beady cardio Beady arrhyth mias Hypersensiti vity Acute angle closure glaucoma Ischemia Obstructive neuropathy  Angina  Nausea  Headache  Vomiting  Sweating Use extreme caution in alkylating & preparing doses Any education of adrenaline that is turn to pink should not be given BP should cheek every 15 minutes The drug should be injected slowly.
  • 55. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICAT ION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 2 ATROPI NE SULHA TE - Oral/ IV se 0.02- 0.15 mg/kg  Anti- cholinergic that inhibits acetyl choline as pares ympa their neuron affect or function Brady cardiac Brady are hythmias Hypersensiti vity Acute angle closure glaucoma Ischemia Obstructive uropathy  Headache  Insomnia  Restlessness  Palpitation  Dey mouth  Constipation Cheek for tacky cardiac Cheek vital signs Monitor I/O chart
  • 56. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 3 IPRATR OPIUM BROMI DE - Inhal ation 0.3%  It inhibits reflux by antagonizing ACH muco curaine receptor on bronchial smooth muscle. Broncho spasm Rhinorr hea Hypersensiti ve  Nausea  Vomiting  Blurred vision  Palpitation  Chest pain  GI distress  dyspnea take care to purulent leakage around the nose the drug should be injected slowly cheek for any side effects
  • 57. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 4 SALBU TAMOL - Oral 1mg/kg 6-8 hrs  it is an odorless white powder  it also relive the pulmonary congestion by constricts the pulmonary arterioles asthma emphys ema bronchit is myocardial insufficiency hyperthyroid ism pregnancy  palpitation  tremors  tachycardia  anorexia  vomiting  nausea cheek for any side effect monitor vital signs administer drug by follows 6 rights
  • 59. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 1 DIGOXI N - Orall y /IV 10- 15mg/k g 0.8- 1mg/kg for loyr children  a cardiac glycoside that increases the influx of cat wine from extracellular to intracellular cytoplasm  it is antiarrhythmic cardiac glycoside CHF Atrial fibrillat ion Paroxys m atrial achy cardiac Ventricular fibrillation Hypersensiti ve Ventricular tacky cardiac Acute MI Sinus beady cardiac Renal disease Hypothec disease  Fatigue  Headache  Malaria  Arrhythmia  Anorexia  Nausea  Vomiting  Diarrhea Do not administer rapidly by IV route to patient receiving diagnosis Instant patient do not take an extra dose of digoxin Advise patient to use some beand constantly
  • 61. SL NO . NAME OF DRUG TRA DE NA ME ROU TE DOSE MODE OF ACTION INDICATIO N CONTRAI NDIRATIO N SIDE EFFECT NURSING RESPONSIBI LITIES 1 CYCL OPHO SPHA MIDE - 2-8 mg/ kg/ day Oral/IV  An alkylating agent that inhibits DNA & RNA protein synthesis by crossing DNA & RNA strands  It preventing cell growth.  It is a potent immune suppressant Nephrotic syndrome Hodgkin’s disease Mycosis Fungoides Retinoblasto ma Breast carcinoma Ovarian adenocarci noma Hypersensi tivity Bone marrow suppresses Impaired renal/replica function Leukopenia Nausea Vomiting Alopecia Diarrhea Darkening of skin Stomatitis Headache Diaphoresis Monitoring CBC, differential, platelet count Renal function studies, BUN.UA, serum, uric acid Take the input output report.
  • 62. SL NO . NAME OF DRUG TRA DE NA ME ROU TE DOSE MODE OF ACTION INDICATIO N CONTRAI NDIRATIO N SIDE EFFECT NURSING RESPONSIBI LITIES 2 VINCR ISTINE SULFA TE - IV 1.4-2 mg/day >10kg 50mg/k g for once weekly  It exceeds it cytotoxic activity by assessing the cell lysis is the metap bone protein of cell division resulting cell lysis  Also inhibits DNA dependent, RNA synthesis Hodgkin disease Neuronblast oma Willm’s tumor Hypersensi tivity Hepatic dysfunction Sensory loss Loss of deep tendon reflexes Diplopia Diarrhea Constipation Nausea Vomiting Anoxia Weight loss Encourage adequate fluid intake to increase urine output
  • 63. SL NO . NAME OF DRUG TRA DE NA ME ROU TE DOSE MODE OF ACTION INDICATIO N CONTRAI NDIRATIO N SIDE EFFECT NURSING RESPONSIBI LITIES 3 METH OTRE XATE - Oral / IV 10-15 mg/day  An anti metabolite that competes enzymes necessary to reduce folic acid to tetra hydro folic acid.  It causes death of cancer cells. Trophoblasti c neoplasm Notify Head & neck cancer Chariot carcinoma Acute lymphocyti c leukemia Rheumatic arthritis Psoriasis Lymph sarcoma Hypersensi tivity Hepatic dysfunction Nausea Vomiting Stomatitis Burning Erythema Diarrhea Rash Dermatitis Provirus Dizziness Alopecia Anorexia Malaria Headache Blurred vission Provide patient fanuly education Notify clinician of black, chills, fever, sere throat, bleeding Diet 10-12 glasses of fluid/day Assess lives function tests
  • 65. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 1 INDIN AVIR SULFA TE Crixi van 500 mg Oral  It prevents cleavage of the viral ply protein by bindings to the protease active site leading from action of immature non- infections viral particles. HIV infectio n Hypersensiti ve Sever hepatic impairment Headache Malaria Insomnia Dizziness Abdominal pain Nausea Vomiting Back pain Insect the patient to drink at least 1.5 L of fluid daily Inform the patient that indinavir is not a cure for HIV infection
  • 66. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 2 ZIDOV UDINE - 160 mg up to 200 mg/k g for neon ate Oral  It will prevents the cleavage of the vital poly proteins by binding to the protease active site HIV infectio ns Hypersensiti ve Diarrhea Acid regulation Dry mouth Flank pain Severe headache Dizziness Convulsions Instruct the patient to drink at least 1.5 L of fluid daily
  • 67. SL NO . NAME OF DRUG TRA DE NAM E RO UTE DOSE MODE OF ACTION INDICA TION CONTRAIN DIRATION SIDE EFFECT NURSING RESPONSIBI LITIES 3 AZIDOT HYMIDI NE - Oral/ IV 200-250 mg every 4- 8 hrs.  It is synthetic analogue of thymidine  It acts by inhibiting viral transcriptase  It crosses placenta  It decreases mortality HIV infectio n Hypersensiti vity  Diarrhea  Nausea  Vomiting  Dizziness  Convulsions Instruct the patient to drink al least 1.5 L of fluid daily Cheek for side effects Monitor continuously